Home News

ROVI completes the manufacture of the first batches of Moderna vaccine

Laboratorios Farmacéuticos Rovi, S.A. (BME -Spanish Stock Exchanges and Markets: ROVI), a pan-European specialised company engaged in the research, development and marketing of biological specialties and a manufacturer with a high degree of technological

Wed, 13/01/2021 - 17:03 0 min
Download related document
No votes yet
 
Related
First nine months 2026 results press release
Total revenue amounted to 633.7 million euros in the first nine months of 2026, up 19% compared to 534.1 million euros in the same...
4 min
05/11/2026
ROVI expresses its deepest sorrow at the death of Ms Fátima Báñez and its...
Madrid, 29 October 2026   Laboratorios Farmacéuticos ROVI expresses its deepest sorrow at the passing of Ms Fátima Báñez García, an...
2 min
29/10/2026
First half 2026 results press release
Total revenue amounted to 357.0 million euros in the first half of 2026, up 13.2% compared to 315.3 million euros in the same period of...
4 min
23/07/2026